Position in AMGN
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$2,992,921
+$134,492 QoQ
Shares Held
8,265
+1.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#1,082
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cooper Financial Group holds $19,451,562 across 11 Drug Manufacturers - General names. AMGN ranks #2 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,274 | $6,325,794 | |
| 2 | AMGN |
Amgen Inc
This page
|
8,265 | $2,992,921 | |
| 3 | ABBV |
AbbVie Inc.
|
11,460 | $2,883,794 | |
| 4 | JNJ |
Johnson & Johnson
|
10,851 | $2,755,828 | |
| 5 | AZN |
Astrazeneca PLC
|
6,342 | $1,202,570 | |
| 6 | MRK |
Merck & Co., Inc.
|
8,089 | $1,039,436 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
12,387 | $713,738 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,403 | $556,275 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,992,921 | 8,265 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $2,858,429 | 8,124 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $2,500,321 | 7,639 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $2,285,255 | 8,098 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $2,305,716 | 8,258 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $2,596,457 | 8,334 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,174,780 | 8,344 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $2,546,103 | 7,902 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,401,490 | 7,686 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $2,393,405 | 8,418 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $2,441,833 | 8,478 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $2,146,854 | 7,988 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $1,788,593 | 8,056 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $1,974,855 | 8,169 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,050,430 | 7,807 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $1,751,358 | 7,770 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $1,856,622 | 7,631 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $1,878,215 | 7,767 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $1,706,847 | 7,587 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,776,903 | 8,356 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $1,987,537 | 8,154 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $1,962,613 | 7,888 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,055,484 | 8,940 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,954,490 | 7,690 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $1,884,757 | 7,991 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $1,136,909 | 5,608 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||